SCHEMBL312401

SCHEMBL312401

CCOC(=O)Nc1nc(O)ccc1-c1cc(=O)c2ccccc2o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.59
HPGD P15428 5/20 0.59
HSD17B10 Q99714 2/20 0.59
LMNA P02545 2/20 0.59
TNKS O95271 4/20 0.51
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
MAOB P27338 3/20 0.46
CSNK2A2 P19784 1/20 0.45
CSNK2B P67870 1/20 0.45
CSNK2A1 P68400 1/20 0.45
RAB9A P51151 3/20 0.45
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311355 0.89 AKR1B1 (0.51) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312214 0.89 HPGD (0.47) KDM4EHPGDHSD17B10LMNAMEN1
SCHEMBL311987 0.87 ATM (0.50) KDM4EHPGDHSD17B10LMNAMEN1
SCHEMBL311535 0.86 HPGD (0.44) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312366 0.85 KDM4E (0.58) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL324201 0.81 HPGD (0.61) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312009 0.81 KDM4E (0.58) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311129 0.80 HPGD (0.63) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311720 0.80 HPGD (0.59) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312126 0.79 MAOB (0.50) KDM4EHPGDHSD17B10LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed